Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
暂无分享,去创建一个
Tongqing Zhou | Gary J. Nabel | Peter D. Kwong | Ling Xu | John R. Mascola | Wei Shi | Zhi-Yong Yang | Johannes F. Scheid | Michel C. Nussenzweig | Lawrence Shapiro | Joseph Sodroski | J. Sodroski | J. Mascola | M. Nussenzweig | G. Nabel | I. Georgiev | T. Zhou | L. Shapiro | P. Kwong | Yongping Yang | Jiang Zhu | Xueling Wu | A. Finzi | K. Dai | Ling Xu | Yongping Yang | Ivelin Georgiev | J. Scheid | W. Shi | Xueling Wu | Kaifan Dai | Jiang Zhu | Andrés Finzi | Young Do Kwon | Young Do Kwon | Zhi-yong Yang
[1] Timothy S. Baker,et al. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon , 1996, Nature.
[2] C. Berek,et al. Maturation of the immune response in germinal centers , 1991, Cell.
[3] Richard T. Wyatt,et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals , 2009, Nature.
[4] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[5] Allen G. Rodrigo,et al. Testing the Hypothesis of a Recombinant Origin of Human Immunodeficiency Virus Type 1 Subtype E , 2000, Journal of Virology.
[6] Douglas D. Richman,et al. Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors , 2007, Journal of Virology.
[7] D. Dimitrov,et al. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens , 2009, Biochemical and Biophysical Research Communications.
[8] J. Mascola,et al. Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 , 2010, Journal of Virology.
[9] John R. Mascola,et al. Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals , 2008, Journal of Virology.
[10] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[11] Peter D. Kwong,et al. Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope , 2004, Journal of Virology.
[12] Xuesong Yu,et al. Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.
[13] S. Harrison,et al. Restraining the conformation of HIV‐1 gp120 by removing a flexible loop , 2006, The EMBO journal.
[14] M L Connolly,et al. The molecular surface package. , 1993, Journal of molecular graphics.
[15] D. Burton. Antibodies, viruses and vaccines , 2002, Nature Reviews Immunology.
[16] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[17] Young Do Kwon,et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.
[18] J. Sodroski,et al. Mutagenic Stabilization and/or Disruption of a CD4-Bound State Reveals Distinct Conformations of the Human Immunodeficiency Virus Type 1 gp120 Envelope Glycoprotein , 2002, Journal of Virology.
[19] David C Montefiori,et al. The role of antibodies in HIV vaccines. , 2010, Annual review of immunology.
[20] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[21] R. Axel,et al. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family , 1985, Cell.
[22] Tongqing Zhou,et al. Mechanism of Human Immunodeficiency Virus Type 1 Resistance to Monoclonal Antibody b12 That Effectively Targets the Site of CD4 Attachment , 2009, Journal of Virology.
[23] Peter D. Kwong,et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.
[24] Mark Connors,et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies , 2007, Nature Medicine.
[25] D. Dimitrov,et al. Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies , 2009, Viruses.
[26] I. Wilson,et al. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation , 1981, Nature.
[27] Wayne A Hendrickson,et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] W A Hendrickson,et al. Energetics of the HIV gp120-CD4 binding reaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] Wayne C Koff,et al. HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.
[30] M. Rossmann. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. , 1989, The Journal of biological chemistry.
[31] Tongqing Zhou,et al. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.
[32] R M Hoet,et al. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. , 1999, Journal of molecular biology.
[33] Lynn Morris,et al. Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C , 2008, Journal of Virology.
[34] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[35] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[36] D. Dimitrov. Therapeutic antibodies, vaccines and antibodyomes , 2010, mAbs.
[37] J. Sodroski,et al. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. , 2010, Molecular cell.
[38] E J Dodson,et al. Collaborative Computational Project, number 4: providing programs for protein crystallography. , 1997, Methods in enzymology.
[39] Peter D. Kwong,et al. The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 , 2002, Journal of Virology.
[40] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[41] Robin A. Weiss,et al. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients , 1985, Nature.
[42] Renate Kunert,et al. Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies , 2005, Science.
[43] G. Sapiro,et al. Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.
[44] Q. Sattentau,et al. Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals , 2010, PloS one.